Candorium Free Members
Join Candorium to access the full article and more
Free Member Benefits:
✔
Comment & Reply✔
Newsletter Access✔
Follow Authors✔
Share via SMS Go Back
Repligen: Q2 Earnings Snapshot
By AP News - Jul 30, 2024, 12:52 PM ET
Last Updated - Jul 30, 2024, 12:52 PM EDT
WALTHAM, Mass. (AP) — WALTHAM, Mass. (AP) — Repligen Corp. (RGEN) on Tuesday reported second-quarter net income of $3.3 million.
On a per-share basis, the Waltham, Massachusetts-based company said it had net income of 6 cents. Earnings, adjusted for non-recurring costs, were 33 cents per share.
Sponsored
The results met Wall Street expectations. The average estimate of seven analysts surveyed by Zacks Investment Research was also for earnings of 33 cents per share.
The drug developer posted revenue of $154.1 million in the period, which missed Street forecasts. Seven analysts surveyed by Zacks expected $154.3 million.
Repligen expects full-year earnings in the range of $1.42 to $1.49 per share, with revenue in the range of $620 million to $635 million.
_____
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RGEN at https://www.zacks.com/ap/RGEN
Sponsored
Read More from Investing
Popular News
Latest News
